Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by RapsAloton Nov 09, 2020 6:49pm
334 Views
Post# 31867603

Name change

Name change
 
Proposed Name Change 
To more accurately reflect the business of the Corporation following its change of business from an 
investment company to a medical company under the rules of the Exchange, the Corporation intends to 
change its name to “Medi-Volve Inc.”, or such other name as the Board may determine and that is 
acceptable to the Exchange and applicable regulatory authorities (the “Name Change”). The Articles will 
be amended to effect the Name Change. The Corporation has reserved the stock symbol “MEDV” with 
the Exchange for such purpose. 
The Board and management of the Corporation, after careful consideration of a number of factors, has 
determined unanimously that the Name Change is in the best interests of the Corporation and its 
Shareholders and authorized the submission of the Name Change to Shareholders for approval by 
special resolution at the Meeting. The Name Change must be passed, with or without variation, by at 
least two-thirds of the votes cast by the Shareholders present in person or by proxy at the Meeting. 
Accordingly, at the Meeting, Shareholders will be asked to approve the following special resolution 
approving the Name Change:
“BE IT RESOLVED AS A SPECIAL RESOLUTION THAT: 
1. subject to QuestCap Inc. (the “Corporation”) first receiving all required regulatory and 
Neo Exchange Inc. approvals, the name of the Corporation be changed to “Medi-Volve 
Inc.” or such other name as may be approved by the board of directors of the Corporation 
(the “Board”) and applicable regulatory authorities; 
2. the articles of the Corporation be amended to reflect the foregoing; 
3. the Board be and are authorized to file articles of amendment and all other requisite 
documents with all applicable regulatory authorities in order to give effect to the name 
change; 
4. notwithstanding the passage of this resolution by the shareholders of the Corporation, the 
Board may, without any further notice or approval of the shareholders of the Corporation, 
decide not to proceed with the name change or to otherwise give effect to this resolution 
at any time prior to the name change becoming effective and may revoke this resolution 
without further approval of the shareholders at any time prior to the completion of the 
transactions authorized by this resolution; and 
5. any one or more of the directors or officers of the Corporation is hereby authorized and 
directed, acting for, in the name of and on behalf of the Corporation, to execute or cause 
to be executed, under the seal of the Corporation or otherwise, and to deliver or cause to 
be delivered, such other documents and instruments, and to do or cause to be done all 
such other acts and things, as may in the opinion of such director or officer of the 
Corporation be necessary or desirable to carry out the intent of the foregoing resolution, 
the execution of any such document or the doing of any such other act or thing by any 
director or officer of the Corporation being conclusive evidence of such determination, 
provided such actions are carried out within the limit of the law.” 
THE BOARD RECOMMENDS THAT SHAREHOLDERS VOTE IN FAVOUR OF THE APPROVAL OF 
THE NAME CHANGE. 
PROXIES RECEIVED IN FAVOUR OF MANAGEMENT WILL BE VOTED FOR THE APPROVAL OF 
THE NAME CHANGE UNLESS A SHAREHOLDER HAS SPECIFIED IN THE PROXY THAT THE 
COMMON SHARES ARE TO BE VOTED AGAINST SUCH SPECIAL RESOLUTION.
<< Previous
Bullboard Posts
Next >>